Send to a Friend Share

Cubist Pharmaceuticals (CBST) volatility low at 49

June 1, 2009 8:26 AM EDT
CBST Hot Sheet
Overall Analyst Rating:
    BUY (Up Up)

EPS Growth %: -18.2%
Cubist Pharmaceuticals (Nasdaq: CBST) closed at $17.06. CBST's Cubicin is the first antibiotic in a new class of anti-infective called lipopeptides. CBST over all option implied volatility of 49 is below its six month average of 57, according to Track Data, suggesting decreasing price movement. Paul Foster

You May Also Be Interested In


Related Categories

Options

Add Your Comment





Follow StreetInsider.com On Twitter